§ Federal grant opportunity · RFA-AI-27-018
Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)
National Institutes of Health is accepting applications for Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional). The deadline is June 20, 2029 and the published award range is Award amount not published.
Key facts
- Funder
- National Institutes of Health
- Application deadline
- June 20, 2029
- Award range
- Award amount not published
- Eligibility
- city or township governments, other, public and state institutions of higher education, for profit organizations other than small businesses, small businesses, state governments, county governments, public and indian housing authorities, private institutions of higher education, special district governments, federally recognized native american tribal governments, other native american tribal organizations, nonprofits non higher education without 501c3, independent school districts, nonprofits non higher education with 501c3
- Geography
- United States
- Focus areas
- Health
- Opportunity number
- RFA-AI-27-018
Program overview
The purpose of this notice of funding opportunity (NOFO) is to support implementation research on strategies to improve the uptake, implementation, sustainment, scale and/or spread of evidence-based prevention, treatment, and care interventions in communities in the U.S. significantly impacted by HIV. Projects should be large in scale with high potential for research and public health impact. Specifically, large single site studies, multi-site studies, and comparative studies are encouraged as scientifically appropriate.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from National Institutes of Health.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before June 20, 2029, allowing time for registration and validation.
Related grant opportunities
- Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
- Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)
- Causal Hypotheses on the Oral-Systemic Health Impacts of Human Behaviors among People with Chronic Conditions (U01 Clinical Trial Not Allowed)
- NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
- NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.